Epigenetic Regulation of T-cell Exhaustion During Treated Chronic HIV Infection
治疗慢性 HIV 感染期间 T 细胞耗竭的表观遗传调控
基本信息
- 批准号:8998914
- 负责人:
- 金额:$ 42.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-01 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdoptive TransferAllelesAntigen-Presenting CellsAntigensAntiviral AgentsAntiviral ResponseAutologousBiological AssayBiological PreservationBlocking AntibodiesCD8B1 geneCell Culture TechniquesCellsChronicCoupledCytomegalovirusDNA MethylationDNA Modification MethylasesEpigenetic ProcessFoundationsGene ExpressionGene Expression RegulationGene TargetingGenerationsGoalsHIVHIV AntigensHIV InfectionsHealthHighly Active Antiretroviral TherapyID2 geneImmune System DiseasesImmune responseIndividualInfectionInterleukin-15Interleukin-2Interleukin-7KineticsLigationMaintenanceMeasuresMediatingMemoryMethodsMethylationMolecularMorbidity - disease rateNucleic Acid Regulatory SequencesPeptidesReportingResearchSignal TransductionStagingT cell responseT-LymphocyteTherapeuticTimeTranscriptional RegulationViralViruscell killingdesignepigenetic regulationexhaustexhaustioninsightkillingslongitudinal analysismortalitynovelprogramspromoterresearch studyresponsesample fixationtherapeutic vaccinewhole genome
项目摘要
DESCRIPTION: Control of HIV infection in individuals treated with highly active antiretroviral therapy (HAART) is the most effective means for reducing mortality and morbidity of chronically infected individuals. We are now challenged with the goal of functionally curing individuals that have HAART suppressed HIV. The HIV reservoir in HAART treated individuals' remains elusive to our current therapeutic strategies so new strategies are now focused on exploiting the inherent potential of HIV-specific CD8 T cells to target and kill infected cells in order to fully resolve the infection or at least maintain control without the use of HAART. In order to utilize th host repertoire of HIV-specific CD8 T cells to achieve the goal of curing HIV infected individuals,
we have to develop strategies that can stably rejuvenate nonfunctional HIV-specific CD8 T cells so that they re-acquire and retain antiviral functions after expansion. To achieve this goal, we have developed a research program that focuses on understanding the mechanism for acquisition and maintenance of acquired gene expression programs in exhausted HIV-specific CD8 T cells. The following aims are designed to identify genes that are targeted for stable epigenetic programming, develop methods for modifying these programs to erase the transcriptional memory of the HIV-specific CD8 T cell, and reactivate the cells in way that facilitates an effective antiviral response during encounter with an HIV-antigen presenting cell. The specific aims of this proposal are: Aim 1. To determine if gene expression program preservation in exhausted HIV-specific CD8 T cells is coupled to maintenance of DNA methylation at transcriptional regulatory regions. a) To identify T-cell exhaustion gene expression programs that are epigenetically preserved following HAART mediated viral control. b) To identify epigenetically poised transcriptional programs in HIV-specific CD8 T cells from HAART treated donors. Aim 2. To identify DNA methylation programs acquired during differentiation of functional HIV-specific CD8 T cells. a) To identify DNA methylation programs specific to functional HIV-specific CD8 T cells in elite controllers. b) To determine if the functional DNA methylation program in EC HIV-specific CD8 T cells is preserved in virus-specific CD8 T cells from other chronic infections. c) To identify the stage of differentiation whe the functional methylation program is lost during progressive exhaustion of HIV-specific CD8 T cells. Aim 3. To determine if modulation of DNA methylation reprogramming of HIV-specific CD8 T cells by - chain signaling and PD-1 signal blockade rescues HIV specific CD8 function and killing. a) To determine if IL-15 mediated differentiation of exhausted CD8 T cells results in short and long term heritable changes in gene regulations. b) To determine if inhibition of PD-1 engagement enhances DNA methylation re- programming of HIV-specific CD8 T cells.
描述:用高度活跃的抗逆转录病毒(HAART)治疗的螺旋菌是最有效的减少疗法的方法。 HAART治疗的个体仍然难以捉摸我们的策略,因此新策略集中在HIV特异性CD8 T细胞靶向和杀死感染细胞的潜力上,以使感染完全解决感染或至少保持控制,而无需使用一半。为了达到HIV特异性CD8 T细胞,以实现固化HIV HIV HIV HIV HIV HIV固化的目标
我们必须制定能够稳定的稳定的非功能性CD8 T细胞,因此它们会在扩展中重新启用抗病毒功能,以实现这一目标。细胞旨在识别基因靶向表观遗传编程,开发用于将程序修改为HIV特异性CD8 T细胞的转录记忆提案的MS是:确定在耗尽的HIV特异性CD8 T细胞中的基因表达程序是在转录调节区域维持DNA甲基化的CD8。 。 The Stage of ONWHE THE THE THE THE THE THE THYLAM IS LOST DURING PURING PROGRESSIVE EXHAUSTION OF HIV-SPECIFIC CD8 T CELLS. AIM 3. To Determine IF METHYLATION OF HIV-SPECIFIC CD8-CHAIN Signaling and PD-1 Signal Blockade RESCUES IFIC CD8功能和杀戮。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin Alan Youngblood其他文献
Benjamin Alan Youngblood的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin Alan Youngblood', 18)}}的其他基金
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
T 细胞耗竭的表观遗传重编程增强肿瘤免疫治疗
- 批准号:
10337284 - 财政年份:2020
- 资助金额:
$ 42.4万 - 项目类别:
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
T 细胞耗竭的表观遗传重编程增强肿瘤免疫治疗
- 批准号:
10558744 - 财政年份:2020
- 资助金额:
$ 42.4万 - 项目类别:
Epigenetic Regulation of T-cell Exhaustion During Treated Chronic HIV Infection
治疗慢性 HIV 感染期间 T 细胞耗竭的表观遗传调控
- 批准号:
9206463 - 财政年份:2015
- 资助金额:
$ 42.4万 - 项目类别:
相似海外基金
Defining astrovirus-specific T cell responses
定义星状病毒特异性 T 细胞反应
- 批准号:
10667003 - 财政年份:2023
- 资助金额:
$ 42.4万 - 项目类别:
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
针对分子定义的难治性黑色素瘤子集的新型细胞治疗方法
- 批准号:
10780289 - 财政年份:2023
- 资助金额:
$ 42.4万 - 项目类别:
Chromatin and transcriptional regulatory factors that initiate and stabilize memory CD8 T cell development
启动和稳定记忆 CD8 T 细胞发育的染色质和转录调节因子
- 批准号:
10488588 - 财政年份:2020
- 资助金额:
$ 42.4万 - 项目类别:
Chromatin and transcriptional regulatory factors that initiate and stabilize memory CD8 T cell development
启动和稳定记忆 CD8 T 细胞发育的染色质和转录调节因子
- 批准号:
10683275 - 财政年份:2020
- 资助金额:
$ 42.4万 - 项目类别:
The impact of HIV adaptation to CD8 T cells on infection and viral control
HIV 对 CD8 T 细胞的适应对感染和病毒控制的影响
- 批准号:
10245517 - 财政年份:2020
- 资助金额:
$ 42.4万 - 项目类别: